What is Mary Evers's NPI number?

Mary Evers's National Provider Identifier (NPI) is 1053533026, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Mary Evers's specialty?

Mary Evers is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Mary Evers located?

Mary Evers's practice location on file with NPPES is 1900 Scenic Dr Ste 2208, Georgetown, TX 78626-7703.

What is Mary Evers's phone number?

The practice phone number listed in the NPPES registry for Mary Evers is (512) 868-9800.

Does Mary Evers accept Medicare?

Mary Evers is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Mary Evers's NPI active?

Yes — Mary Evers's NPI (1053533026) is active in the NPPES registry as of the last update on 2019-07-23.

IndividualActiveAccepts Medicare

Mary Evers, DO

NPI 1053533026 · Dermatology Physician · Georgetown, TX

Mary Evers, DO is a Dermatology Physician provider in Georgetown, TX (NPI 1053533026).

Provider details

NPI number: 1053533026
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: DO
Sex: Female
Sole proprietor: No
License: M6125 (TX)

Practice location

1900 Scenic Dr Ste 2208

Georgetown, TX 78626-7703

Phone: (512) 868-9800

Fax: (512) 868-9811

Street-level locationGet directions

More TX providers

Mailing address

1900 Scenic Dr Ste 2208

Georgetown, TX 78626-7703

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense M6125 (TX)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(93/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
12,719 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	5,829	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,563	$87
Destruction of Precancer Skin Growth, 1 Growth17000	1,233	$45
Biopsy of Related Skin Growth, First Growth11102	896	$85
Destruction of Precancer Skin Growth, 15 Or More Growths17004	763	$159
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Mupirocin	279	218
Triamcinolone Acetonide	223	173
Ketoconazole	134	77
Dutasteride	132	48
Fluocinonide	119	89
Clobetasol Propionate	88	56
Valacyclovir Hclbrand: Valacyclovir	80	36
Doxycycline Hyclate	75

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$209 across 9 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-05-02
Last updated: 2019-07-23

Frequently asked questions

What is Mary Evers's NPI number?: Mary Evers's National Provider Identifier (NPI) is 1053533026, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Mary Evers's specialty?: Mary Evers is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Mary Evers located?: Mary Evers's practice location on file with NPPES is 1900 Scenic Dr Ste 2208, Georgetown, TX 78626-7703.
What is Mary Evers's phone number?: The practice phone number listed in the NPPES registry for Mary Evers is (512) 868-9800.
Does Mary Evers accept Medicare?: Mary Evers is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Mary Evers's NPI active?: Yes — Mary Evers's NPI (1053533026) is active in the NPPES registry as of the last update on 2019-07-23.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	5,829	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,563	$87
Destruction of Precancer Skin Growth, 1 Growth17000	1,233	$45
Biopsy of Related Skin Growth, First Growth11102	896	$85
Destruction of Precancer Skin Growth, 15 Or More Growths17004	763	$159
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214

Drug

Part D claims (2024)

Beneficiaries

Mupirocin

279

218

Triamcinolone Acetonide

223

173

Ketoconazole

134

Dutasteride

132

Fluocinonide

119

Clobetasol Propionate

Valacyclovir Hclbrand: Valacyclovir

Doxycycline Hyclate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$209 across 9 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments